Intersect ENT Announces FDA Approval of New Steroid-Releasing Implant, Allowing More Chronic Sinusitis Patients to Benefit from Localized Drug Delivery PROPEL™ mini Offers Same Clinical Benefits and Dose of Mometasone - Sinus implant - Document - PDFSEARCH.IO

First Page	Meta Content
	Intersect ENT Announces FDA Approval of New Steroid-Releasing Implant, Allowing More Chronic Sinusitis Patients to Benefit from Localized Drug Delivery PROPEL™ mini Offers Same Clinical Benefits and Dose of Mometasone Add to Reading List Document Date: 2014-04-17 10:10:29 Open Document File Size: 31,86 KB Share Result on Facebook

UPDATE

Intersect ENT Announces FDA Approval of New Steroid-Releasing Implant, Allowing More Chronic Sinusitis Patients to Benefit from Localized Drug Delivery PROPEL™ mini Offers Same Clinical Benefits and Dose of Mometasone Add to Reading List